<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02129907</url>
  </required_header>
  <id_info>
    <org_study_id>thrombingeneration- anemia</org_study_id>
    <nct_id>NCT02129907</nct_id>
  </id_info>
  <brief_title>The Purpose of the Study is to Examine Whether Iron Deficiency Anemia is Associated With Increased Production of Thrombin and Whether Correction of Anemia by Providing Iron Intravenously Causes a Significant Reduction in Production of Thrombin.</brief_title>
  <official_title>The Purpose of the Study is to Examine Whether Iron Deficiency Anemia is Associated With Increased Production of Thrombin and Whether Correction of Anemia by Providing Iron Intravenously Causes a Significant Reduction in Production of Thrombin.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In total 50 subjects with iron deficiency anemia treated with intravenous iron are planned&#xD;
      for inclusion in this trial. After signing an informed consent a blood sample will be&#xD;
      obtained from each participant before iron treatment. The investigators will measure the&#xD;
      thrombin generation in plasma assessed by the calibrated automated thrombogram (CAT). patient&#xD;
      will go face to face interview and will be asked to answer structured questionnaire which&#xD;
      will include information on demographics, clinical data ( fever, allergies , etc.) and&#xD;
      comorbidities&#xD;
&#xD;
      Two weeks after completing intravenous iron administration additional blood samples will be&#xD;
      taken: thrombin generation will be measured&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Weeks</target_duration>
  <primary_outcome>
    <measure>thrombin generation levels</measure>
    <time_frame>10 weeks</time_frame>
  </primary_outcome>
  <enrollment type="Actual">82</enrollment>
  <condition>Iron Deficiency Anemias</condition>
  <eligibility>
    <study_pop>
      <textblock>
        men and women over age 18 suffering from iron deficiency anemia that wasnt responded to&#xD;
        oral iron treatment or there is contraindication for oral iron therapy.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age &gt;18 years&#xD;
&#xD;
          -  Iron deficiency anemia that did not response to oral iron treatment and is planned to&#xD;
             receive iron supplement intravenously.&#xD;
&#xD;
          -  Signing the informed consent&#xD;
&#xD;
        exclusion criteria:&#xD;
&#xD;
          -  chronic inflammatory disease&#xD;
&#xD;
          -  renal failure&#xD;
&#xD;
          -  Malignancy&#xD;
&#xD;
          -  Infectious disease&#xD;
&#xD;
          -  Other reason for anemia except iron deficiency anemia.&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Use of anti aggregating agents or anticoagulants&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Haemek medical center</name>
      <address>
        <city>Afula</city>
        <zip>1834111</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <study_first_submitted>May 1, 2014</study_first_submitted>
  <study_first_submitted_qc>May 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 2, 2014</study_first_posted>
  <last_update_submitted>December 17, 2018</last_update_submitted>
  <last_update_submitted_qc>December 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>HaEmek Medical Center, Israel</investigator_affiliation>
    <investigator_full_name>Elias mazen</investigator_full_name>
    <investigator_title>prof mazen elias</investigator_title>
  </responsible_party>
  <keyword>Anemias</keyword>
  <keyword>Iron-Deficiency</keyword>
  <keyword>thrombin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
    <mesh_term>Deficiency Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

